Cargando…
Non-Covalent BTK Inhibitors—The New BTKids on the Block for B-Cell Malignancies
The B-cell receptor signalling pathway plays a critical role in development of B-cell malignancies, and the central role of Bruton’s tyrosine kinase (BTK) activation in this pathway provides compelling rationale for BTK inhibition as a therapeutic strategy for these conditions. Covalent BTK inhibito...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400141/ https://www.ncbi.nlm.nih.gov/pubmed/34442408 http://dx.doi.org/10.3390/jpm11080764 |